Cover Image
Market Research Report
Product code 
1026875

CPAP Market Shares, Market Strategies and Market Forecasts, 2021 to 2026

Published: | WinterGreen Research, Inc. | 110 Pages; 61 Tables & Figures | Delivery time: 1-2 business days

Price

Back to Top
CPAP Market Shares, Market Strategies and Market Forecasts, 2021 to 2026
Published: September 1, 2021
WinterGreen Research, Inc.
Content info: 110 Pages; 61 Tables & Figures
Delivery time: 1-2 business days
  • Description
  • Table of Contents
  • List of Tables

Worldwide markets are poised to achieve continuing growth as CPAP prove value by providing airway support during sleep to a larger percent of the worldwide population.

The CPAP study provides a compelling case for putting devices off prescription. Despite devices being on the market since 1980, less than 20% of the people who need them have a CPAP device. The pressure delivered air during sleep is able to mitigate the onset of high blood pressure, cardiac arrythmia, and type 2 diabetes. These chronic diseases represent a significant part of the cost of healthcare delivery. To be able to mitigate the onset of severity of chronic disease is of interest to every healthcare provider.

A strong association has been discovered between sleep apnea and a number of cardiovascular and metabolic diseases. Studies have shown that sleep apnea is present in approximately 83% of patients with drug-resistant hypertension. While sleep apnea has been diagnosed in a broad cross-section of the population, until recently, it has typically been used to treat middle-aged, middle and upper class white men who are obese. The importance of sleep apnea in people is increasingly being recognized. 40% of new PAP patients are female.

Taking CPAP devices off prescription would move the current recommender base to vendors. Putting the onus of education on CPAP vendors who typically have very large marketing budgets and access to TV and other advertising venues is likely to be a positive move in the industry.

It is estimated that less than 20% of those with OSA have been diagnosed or treated. This data provides compelling reasons to take CPAP devices off prescription. Many healthcare professionals are often unable to diagnose OSA because they are unaware that non-specific symptoms as excessive daytime sleepiness, snoring, hypertension and irritability are characteristic of OSA.

Product Code: SH28994732

Table of Contents

Abstract: CPAP Markets Poised to Grow as Devices Become Available without Prescription

CPAP Executive Summary

  • Major Growth Opportunity
  • Taking CPAP Devices off Prescription
  • CPAP Fundamentals
  • Philips CPAP Recall
    • Toxicity
  • CPAP Regional Analysis

1. CPAP: Market Description and Market Dynamics

  • 1.1 What Causes Sleep Apnea?

2. CPAP Market Shares and Forecasts

  • 2.1 CPAP Market Driving Forces
    • 2.1.1 Covid19 Pandemic CPAP Market Impact
  • 2.2 CPAP Market Shares
    • 2.1.1 CPAP / BiPAP / APAP Market Unit Analysis
  • 2.3 CPAP / BiPAP / APAP Forecasts
    • 2.3.2 CPAP / BiPAP / APAP Unit Analysis
    • 2.1.2 CPAP /BiPAP / APAP Installed Units
  • 2.4 CPAP / BiPAP / APAP Market Segment Forecasts
    • 2.4.1 CPAP
    • 2.4.2 BiPAP
    • 2.4.3 APAP
    • 2.1.2 Strategic Planning Factors
  • 2.5 CPAP Prices
    • 2.5.1 ResMed AirSense 10, Price $833
    • 2.5.2 Philips Respironics DreamStation 2
    • 2.5.3 Fisher & Paykel SleepStyle Auto CPAP
    • 2.5.4 China CPAP 100
  • 2.6 CPAP Regional Analysis

3. Philips' CPAP Recall and CPAP Positioning: Market Opportunity

  • 3.1 Philips' CPAP Recall Notification 2021
  • 3.2 Polyester-Based Polyurethane (PE-PUR) Sound Abatement Foam Could Cause Harmful Side Effects
    • 3.2.1 Philips' CPAP Recall Devices Impacted
  • 3.3 Philips CPAP Recall
    • 3.3.1 Philips' CPAP Recall Notification 2021 and Solutions
  • 3.4 Legal Protection from Dangerous Medical Devices
  • 3.5 Sleep Fragmentation
  • 3.6 Automatic Positive Airway Pressure Monitoring Devices
  • 3.7 Obesity Hypoventilation Syndrome
  • 3.8 Neuromuscular Disease
  • 3.9 CPAP Market Extended by Home Monitoring and Automated Settings
  • 3.10 Sleep

4. CPAP Healthcare Coverage and Technology

  • 4.1 26% Of Adults Age 30-70 Have Some Form of Obstructive Sleep Apnea
  • 4.2 Common Type of OSA Mask

5. CPAP Company Profiles

  • 5.1 3B Medical
  • 5.2 Apex
    • 5.2.1 Apex PVA Pressure Variation Algorithm
    • 5.2.2 Apex Enhanced Pressure Stability
    • 5.2.3 Apex Medical Revenue
  • 5.3 BMC Medical
  • 5.4 Fosun Pharma / Breas
    • 5.4.1 Fosun Pharma 2020 Revenue
    • 5.4.2 Breas
  • 5.5 Medical Depot / Drive Medical / DeVilbiss
    • 5.5.1 Drive Medical / DeVilbiss CPAP
    • 5.5.2 Drive DeVilbiss Healthcare Response to Philips CPAP Recall
    • 5.5.3 Drive Medical Revenue
  • 5.6 Fisher & Paykel
    • 5.6.1 Fisher & Paykel SleepStyle Auto CPAP
      • Fisher Paykel Modem - Automated Data Transfer Via Internet and Cellular Network
  • 5.7 Philips
    • 5.7.1 Respironics DreamStation Auto Quiet CPAP
    • 5.7.2 Philips Healthcare Revenue
    • 5.7.3 Philips Connected Care Businesses
  • 5.8 ResMed
    • 5.8.1 ResMed AirMini Travel CPAP
    • 5.8.2 ResMed AirSense 10 CPAP
    • 5.8.3 ResMed AirSense 10 AutoSet CPAP
    • 5.8.4 ResMed Sleep and Respiratory Care Revenue
  • 5.9 Signifier Medical Technologies
  • 5.10 Smiths Group
  • 5.11 T A Associates
  • 5.12 Teijin Pharma Limited
  • 5.11 Selected List of CPAP Companies

6. Table of Contents

WinterGreen Research,

  • WinterGreen Research Methodology
  • WinterGreen Research Process
  • Market Research Study
  • WinterGreen Research Global Market Intelligence Company
  • Report Description: Software and Revenue Models Matter

List of Figures

  • Figure 1. CPAP / BiPAP / APAP Regional Market Segments, Dollars, 2020
  • Figure 2. CPAP / BiPAP / APAP Regional Market Segments, Dollars, 2020
  • Figure 3. Common Risk Factors for Sleep Apnea
  • Figure 4. CPAP Parts and Functions
  • Figure 5. CPAP Machine User Problems
  • Figure 6. Mayo Clinic Common CPAP Problems and Solutions
  • Figure 7. CPAP / BiPAP / APAP Market Shares, Dollars, 2020
  • Figure 8. CPAP / BiPAP / APAP Market Shares, Combined Total, Dollars, Worldwide, 2020
  • Figure 9. CPAP / BiPAP / APAP Market Shares, in Dollars, Worldwide, 2020
  • Figure 10. CPAP / BiPAP / APAP Market Shares, in Percent, Dollars, Worldwide, 2020 21
  • Figure 11. CPAP / BiPAP / APAP Market Shares, Units, Worldwide, 2020
  • Figure 12. CPAP / BiPAP / APAP Market Shares, Percent, Units, Worldwide, 2020 23
  • Figure 13. CPAP / BiPAP / APAP Market Shares, $ per Unit, Unit Analysis, Worldwide, 2020
  • Figure 14. CPAP / BiPAP / APAP Forecasts Dollars, Worldwide, 2021-2027
  • Figure 15. CPAP / BiPAP / APAP Forecasts Dollars, Worldwide, 2021-2027
  • Figure 16. Respiratory Care Key Market Growth Elements
  • Figure 17. CPAP /BiPAP APAP Installed Units, Worldwide, 2021-2027
  • Figure 18. CPAP Fundamentals
  • Figure 19. CPAP Market Forecasts, Dollars, Worldwide, 2021-2027
  • Figure 20. BiPAP Market Forecasts, Dollars, Worldwide, 2021-2027
  • Figure 21. APAP Market Forecasts, Dollars, Worldwide, 2021-2027
  • Figure 22. CPAP / BiPAP / APAP Market Segments, Dollars, Percent of Total, Worldwide, 2021
  • Figure 23. CPAP / BiPAP / APAP Market Segments, Dollars, Percent of Total, Worldwide, 2027
  • Figure 24. CPAP / BiPAP / APAP Market Segments, Dollars and Percent of Total, Worldwide, 2021-2027
  • Figure 25. Fisher & Paykel SleepStyle Auto CPAP Machine
  • Figure 26. CPAP 100 Loud Devices
  • Figure 27. CPAP / BiPAP / APAP Regional Market Segments, Dollars, 2020
  • Figure 28. CPAP / BiPAP / APAP Regional Market Segments, Dollars, 2020
  • Figure 29. CPAP / BiPAP / APAP Regional Market Segments, Dollars, 2020
  • Figure 30. FDA Philips Respironics CPAP and Ventilator Models Recalled
  • Figure 31. Philips DreamStation Recalled
  • Figure 32. Philips DreamStation ASV Recalled
  • Figure 33. Philips DreamStation ST, AVAPS Recalled
  • Figure 34. Philips DreamStation CPAP, Auto CPAP, BiPAP and other Devices Recalled 51
  • Figure 35. CPAP Nighttime Mask
  • Figure 36. 3B Medical CPAP
  • Figure 37. 3B Medical CPAP Features
  • Figure 38. Multi-Stage Noise Reduction Technology
  • Figure 39. Apex CPAP
  • Figure 40. Apex Enhanced Pressure Stability Functions
  • Figure 41. BMC CPAP / APAP Products
  • Figure 42. Drive Medical / DeVilbiss CPAP
  • Figure 43. Drive Medical CPAP Features
  • Figure 44. Fisher & Paykel SleepStyle Auto CPAP Machine
  • Figure 45. Filtration Efficiencies of F&P Filters
  • Figure 46. Fisher & Payke Revenue
  • Figure 47. Respironics DreamStation Functions and Difficulties
  • Figure 48. Philips Respironics Dream Station CPAP
  • Figure 49. Philips Group Revenue 2020
  • Figure 50. ResMed AirMini Travel CPAP Features
  • Figure 51. ResMed AirSense 10 AutoSet CPAP
  • Figure 52. ResMed AirSense 10 AutoSet
  • Figure 53. ResMed CPAP Functions
  • Figure 54. ResMed CPAP Products
  • Figure 55. ResMed Revenue 2020
  • Figure 56. ResMed Regional Revenue Segments
  • Figure 57. ResMed Sleep and Respiratory Care Revenue
  • Figure 58. Signifier Medical Technologies (SMT) Daytime Device that Strengthens the Throat 90
  • Figure 59. Smiths Group Financial Performance F/I 2020
  • Figure 60. Smiths Group Regional Financial Performance F/I 2020
  • Figure 61. Smiths Group Revenue F/I 2020